Yinxiang Wei

Gypenosides improve diabetic cardiomyopathy by inhibiting <scp>ROS</scp>‐mediated <scp>NLRP</scp>3 inflammasome activation

Hailong Zhang, Xi Chen, Beibei Zong et al. · Journal of Cellular and Molecular Medicine · 2018 · 163 citations · Full text

A novel IL‐23p19/Ebi3 (IL‐39) cytokine mediates inflammation in Lupus‐like mice

Xiaoqian Wang, Yinxiang Wei, Xiao He et al. · European Journal of Immunology · 2016 · 159 citations · Full text

Exosomes with membrane‐associated TGF‐β1 from gene‐modified dendritic cells inhibit murine EAE independently of MHC restriction

Lei Yu, Fei Yang, Lingling Jiang et al. · European Journal of Immunology · 2013 · 79 citations · Full text

Immunology, Immune Regulation, Immunologic Mechanism +27

New Use for an Old Drug: Inhibiting ABCG2 with Sorafenib

Yinxiang Wei, Yuanfang Ma, Qing Zhao et al. · Molecular Cancer Therapeutics · 2012 · 51 citations

Drug Target, Chemoprevention Strategy, Pharmacotherapy +18

Post-transcriptional regulator Rbm47 elevates IL-10 production and promotes the immunosuppression of B cells

Yinxiang Wei, Fanghui Zhang, Yu Zhang et al. · Cellular and Molecular Immunology · 2018 · 50 citations · Full text